Dr. Schroth has previously worked as a paid consultant to Biogen , which is selling the drug .The drug , called Spinraza , will not come cheap   â€”    and , by some estimates , will be among the most expensive drugs in the world .Biogen , which is licensing Spinraza from Ionis Pharmaceuticals , said this week that one dose will have a list price of $ 125 , 000 .That means the the drug cost $ 625 , 000 to $ 750 , 000 to cover the five or six doses needed in the first year , and about $ 375 , 000 annually after that , to cover the necessary three doses a year .